LENTIGEN TECHNOLOGY INC has a total of 11 patent applications. It increased the IP activity by 600.0%. Its first patent ever was published in 2016. It filed its patents most often in Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are LENTIGEN TECH INC, CYTOIMMUNE THERAPEUTICS LLC and ORIGINCELL THERAPEUTICS CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 11 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Dropulic Boro | 11 |
#2 | Schneider Dina | 11 |
#3 | Dimitrov Dimiter S | 6 |
#4 | Orentas Rimas | 6 |
#5 | Zhu Zhongyu | 6 |
#6 | Orentas Rimas J | 5 |
#7 | Miltenyi Stefan | 2 |
#8 | Haso Waleed M | 2 |
#9 | Krueger Winfried | 1 |
#10 | Anthony-Gonda Kim | 1 |
Publication | Filing date | Title |
---|---|---|
AU2018388997A1 | Compositions and methods for treating HIV/AIDS with immunotherapy | |
AU2018205372A1 | Compositions and methods for treating cancer with anti-mesothelin immunotherapy |